Document is current
Any future updates will be listed below
-
Authors
Escrichs, Anira https://orcid.org/0000-0002-6482-9737
Sanz Perl, Yonatan
Fisher, Patrick M. https://orcid.org/0000-0002-8115-0611
MartÃnez-Molina, Noelia
G-Guzman, Elvira
Frokjaer, Vibe G.
Kringelbach, Morten L. https://orcid.org/0000-0002-3908-6898
Knudsen, Gitte M.
Deco, Gustavo https://orcid.org/0000-0002-8995-7583
- License Information
-
More Information
Article History
Received: 14 February 2024
Revised: 25 July 2024
Accepted: 31 July 2024
First Online: 10 September 2024
Competing interests
: The authors declare no competing interests.
: This clinical trial was approved by the local scientific ethics committee (H-15017713), the Danish Data Protection Agency, and Danish Medicines Agency (NeuroPharm-NP1, EudraCT number: 2016-001626-34). The study complied with the Declaration of Helsinki II, and a Good Clinical Practice monitoring unit in the Capital Region of Denmark. All participants signed written informed consent after receiving oral and written descriptions of the study.
